Original Article

Lower Serum Levels of Uric Acid in Uterine Fibroids and Fibro-cystic Breast Disease Patients in Dongying City, China


Background: Increasing serum levels of uric acid (SUA) after menopause in women brought up a hypothesis that estrogenic effect may protectively regulate SUA. Estrogenic effect is a major etiology of uterine fibroids and fibrocystic breast disease. The study aimedtoexplore SUA among patients suffering from these diseases to enhance the hypothesis.

Methods: Overall, 1349 female participants were selected into three cases: CaseⅠhaving uterine fibroids (n=568), CaseⅡ having fibrocycstic breast disease (n=608) and CaseⅢ having uterine fibroids combining with fibrocycstic breast disease (n=173); 4206 participants without these diseases were selected as controls. Based on health check-up data from 2011 to 2012, in Dongying Shengli Oilfield Central Hospital, a cross-sectional study was conducted to examine the difference in SUA between the case and control. We adjusted covariates by generalized linear regression mode.

Results: From 19 to 44 yr, SUA of CaseⅠ to CaseⅢ were lower than controls by 8.46 umol/L (P=0.011), 5.88umol/L (P=0.014) and 9.39 umol/L (P=0.059), respectively. From 45-54 yr, no significant differences were between three cases and controls. In CaseⅠand its control: from 54-59 yr, differences were not significant; from 60 to 72 yr, SUA in CaseⅠwas lower than the control by 32.02umol/L (P=0.003).

Conclusion: Participants of uterine fibroids and fibrocystic breast disease had a lower SUA except the stage of menopause, which indirectly supported that estrogenic effect, may protectively decrease SUA.



Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF (2012). Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed), 17:656-669.

Fang J, Alderman MH (2000). Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA, 283:2404-2410.

Long CL, Qin XC, Pan ZY, Chen K, Zhang YF, Cui WY, Liu GS, Wang H (2008). Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia. J Hypertens, 26:2326-2338.

Ford ES, Li C, Cook S, Choi HK (2007). Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation, 115:2526-2532.

Tuttle KR, Short RA, Johnson RJ (2001). Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol, 87:1411-1414.

Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, Jinnah HA (2007). Serum uric acid and brain ischemia in normal elderly adults. Neurology, 69:1418-1423.

Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY (2006). Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension, 47:962-967.

B L, T W, Hn Z, Ww Y, Hp Y, Cx L, J Y, Ry J, Hw N (2011). The prevalence of hyperuricemia in China: a meta-analysis. BMC Public Health, 11:832.

Khosla UM, Zharikov S, Finch JL et al. (2005). Hyperuricemia induces endothelial dysfunction. Kidney Int, 67:1739-1742.

Shi Y, Evans JE, Rock KL (2003). Molecular identification of a danger signal that alerts the immune system to dying cells. Nature, 425:516-521.

Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006). Uric acid and inflammatory markers. Eur Heart J, 27:1174-1181.

Kanellis J, Kang DH (2005). Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol, 25:39-42.

Hak AE, Choi HK (2008). Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey. Arthritis Res Ther, 10:R116.

Cremonini E, Bonaccorsi G, Bergamini CM, Castaldini C, Ferrazzini S, Capatti A, Massari L, Romani A, Marci R, Fila E, Ferrari C, Cervellati C (2013). Metabolic transitions at menopause: in post-menopausal women the increase in serum uric acid correlates with abdominal adiposity as assessed by DXA. Maturitas, 75:62-66.

Mascarenhas-Melo F, Marado D, Palavra F, Sereno J, Coelho A, Pinto R, Teixeira-Lemos E, Teixeira F, Reis F (2013). Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovasc Diabetol, 12:61.

Mascarenhas-Melo F, Sereno J, Teixeira-Lemos E, Ribeiro S, Rocha-Pereira P, Cotterill E, Teixeira F, Reis F (2013). Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations. Dis Markers, 35:85-96.

Moon SS (2013). Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. Ann Nutr Metab, 62:158-163.

Yahyaoui R, Esteva I, Haro-Mora JJ et al. (2008). Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab, 93:2230-2233.

Takiue Y, Hosoyamada M, Kimura M, Saito H (2011). The effect of female hormones upon urate transport systems in the mouse kidney. Nucleosides Nucleotides Nucleic Acids, 30:113-119.

Bradlow HL, Rosenfeld RS, Kream J, Fleisher M, O'Connor J, Schwartz MK (1981). Steroid hormone accumulation in human breast cyst fluid. Cancer Res, 41:105-107.

Okolo S (2008). Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol, 22:571-588.

Parker WH (2007). Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril, 87:725-736.

(2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 39:S1-266.

Xie H (2004). Ultrasonographic Diagnosis in Obstetrics & Gynecology. ed. People's Medical Publishing House, China, pp.: 168-228.

JC W (2013). Breast hyperplastic diseases. In: Diagnosis and treatment in benign breast diseases. Ed (s), Zhang Z, Wu JC, pp. 155-156.

Li L, Wu J, Pu D, et al. (2012). Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas, 73:354-360.

Eckey T, Neumann A, Bohlmann MK, Barkhausen J, Hunold P (2011). [Non-invasive thermoablation of symptomatic uterine fibroids with magnetic resonance-guided high-energy ultrasound]. Radiologe, 51:610-619.

Bachmann G (2001). Physiologic aspects of natural and surgical menopause. J Reprod Med, 46:307-315.

Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Boon WC, Simpson ER, Davis SR (2005). Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas, 51:299-306.

Burns KA, Korach KS (2012). Estrogen receptors and human disease: an update. Arch Toxicol, 86:1491-1504.

Feng Y, Lin X, Zhou S, Xu N, Yi T, Zhao X (2013). The associations between the polymorphisms of the ER-alpha gene and the risk of uterine leiomyoma (ULM). Tumour Biol, 34:3077-3082.

Wren BG (1996). The breast and the menopause. Baillieres Clin Obstet Gynaecol, 10:433-447.

Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, Rosenberg L (2005). Influence of Body Size and Body Fat Distribution on Risk of Uterine Leiomyomata in U.S. Black Women. Epidemiology, 16:346-354.

Baird DD, Travlos G, Wilson R, Dunson DB, Hill MC, D'Aloisio AA, London SJ, Schectman JM (2009). Uterine leiomyomata in relation to insulin-like growth factor-I, insulin, and diabetes. Epidemiology, 20:604-610.

He Y, Zeng Q, Li X, Liu B, Wang P (2013). The association between subclinical atherosclerosis and uterine fibroids. PLoS One, 8:e57089.

Kaygusuz I, Gumus, II, Yuvaci HU, Kasapoglu B, Carlioglu A (2012). Does hormone replacement therapy have beneficial effects on renal functions in menopausal women? Arch Gynecol Obstet, 285:1643-1646.

Luo N, Guan Q, Zheng L, Qu X, Dai H, Cheng Z (2014). Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res, 163:232-241.

Clegg DJ (2012). Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol, 26:1957-1960.

Wang W, Liou TH, Lee WJ, Hsu CT, Lee MF, Chen HH (2014). ESR1 gene and insulin resistance remission are associated with serum uric acid decline for severely obese patients undergoing bariatric surgery. Surg Obes Relat Dis, 10:14-22.

Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA (2002). High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes, 51:1889-1895.

Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torrens JI (2005). Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation, 111:1242-1249.

Diamanti-Kandarakis E, Lambrinoudaki I, Economou F, Christou M, Piperi C, Papavassiliou AG, Creatsas G (2010). Androgens associated with advanced glycation end-products in postmenopausal women. Menopause, 17:1182-1187.

Poutanen M (2012). Understanding the diversity of sex steroid action. J Endocrinol, 212:1-2.

Gong H, Jarzynka MJ, Cole TJ et al. (2008). Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res, 68:7386-7393.

Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T (1999). Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet, 354:650.

Favre J, Gao J, Henry JP et al. (2010). Endothelial estrogen receptor {alpha} plays an essential role in the coronary and myocardial protective effects of estradiol in ischemia/reperfusion. Arterioscler Thromb Vasc Biol, 30:2562-2577.

Maleeva A, Milkov V (1991). [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues]. Akush Ginekol (Mosk), (5): 55-57.

Brandon DD, Erickson TE, Keenan EJ, et al. (1995). Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab, 80:1876-1881.

IssueVol 45 No 5 (2016) QRcode
SectionOriginal Article(s)
Uric acid Estrogenic effect Leiomyoma and fibrocyst Breast disease

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
CHEN Q, XIAO J, ZHANG P, CHEN L, CHEN X, WANG S. Lower Serum Levels of Uric Acid in Uterine Fibroids and Fibro-cystic Breast Disease Patients in Dongying City, China. Iran J Public Health. 2016;45(5):596-605.